You are here
2 pharma firms to mine gene data from 500,000 Britons
BRITAIN'S GlaxoSmithKline and US-based Regeneron Pharmaceuticals are embarking on a joint project with UK Biobank, the world's most detailed biomedical database, to hunt for new clues linking genes and disease.
By analysing genetic variations and health in 500,000 middle-
CALL +65 6388 3838 EMAIL email@example.com